ACM
MIRM icon

Altium Capital Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Altium Capital Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-208,000
Closed -$5.22M – 75
2024
Q1 		$5.22M Buy
+208,000
New +$5.72M 2.07% 20

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Altium Capital Management's MIRM Position: Q2 2024 in Review

Altium Capital Management sold out of Mirum Pharmaceuticals (MIRM) in Q2 2024, closing a stake of 208,000 shares — an estimated $5.22M sold.

Altium Capital Management first reported a position in MIRM in Q1 2024 and held it in 1 quarter. The position peaked at $5.22M in Q1 2024. 160 funds tracked by Wall St. Rank hold MIRM as of Q2 2024.

  • Altium Capital Management reported no remaining Mirum Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Altium Capital Management sold 208,000 Mirum Pharmaceuticals shares in Q2 2024, an estimated $5.22M.
  • Altium Capital Management first reported a position in Mirum Pharmaceuticals in Q1 2024 and held it in 1 quarter.
  • Altium Capital Management's Mirum Pharmaceuticals position peaked at $5.22M in Q1 2024.
  • 160 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2024.

Based on Altium Capital Management's 13F filing for Q2 2024, filed 15 Aug 2024.